[go: up one dir, main page]

Velappan et al., 2021 - Google Patents

Construction, characterization and crystal structure of a fluorescent single-chain Fv chimera

Velappan et al., 2021

View HTML
Document ID
1139117254391018314
Author
Velappan N
Close D
Hung L
Naranjo L
Hemez C
DeVore N
McCullough D
Lillo A
Waldo G
Bradbury A
Publication year
Publication venue
Protein Engineering, Design and Selection

External Links

Snippet

In vitro display technologies based on phage and yeast have a successful history of selecting single-chain variable fragment (scFv) antibodies against various targets. However, single-chain antibodies are often unstable and poorly expressed in Escherichia coli. Here …
Continue reading at academic.oup.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1062—Isolating an individual clone by screening libraries mRNA-Display, e.g. polypeptide and encoding template are connected covalently
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Similar Documents

Publication Publication Date Title
McMahon et al. Yeast surface display platform for rapid discovery of conformationally selective nanobodies
Chen et al. A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
Tereshko et al. Toward chaperone‐assisted crystallography: protein engineering enhancement of crystal packing and X‐ray phasing capabilities of a camelid single‐domain antibody (VHH) scaffold
Sahtoe et al. Reconfigurable asymmetric protein assemblies through implicit negative design
Braun et al. Peptides in headlock–a novel high-affinity and versatile peptide-binding nanobody for proteomics and microscopy
Schmitz et al. Structural evaluation of EGFR inhibition mechanisms for nanobodies/VHH domains
Sethi et al. Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response
McConnell et al. An integrated approach to extreme thermostabilization and affinity maturation of an antibody
Correa et al. Potent and specific inhibition of glycosidases by small artificial binding proteins (Affitins)
Millward et al. In situ click chemistry: from small molecule discovery to synthetic antibodies
Sahtoe et al. Transferrin receptor targeting by de novo sheet extension
Zhao et al. Broadening a SARS-CoV-1–neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution
Bacon et al. Screening yeast display libraries against magnetized yeast cell targets enables efficient isolation of membrane protein binders
Velappan et al. Construction, characterization and crystal structure of a fluorescent single-chain Fv chimera
Sevy et al. Structure-and sequence-based design of synthetic single-domain antibody libraries
Nannini et al. Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments
Steemson et al. Tracking molecular recognition at the atomic level with a new protein scaffold based on the OB-fold
Kajiwara et al. Development of a yeast cell surface display method using the SpyTag/SpyCatcher system
Weaver-Feldhaus et al. Directed evolution for the development of conformation-specific affinity reagents using yeast display
Zeytun et al. Fluorobodies combine GFP fluorescence with the binding characteristics of antibodies
Wang et al. Development of a functional antibody by using a green fluorescent protein frame as the template
Senutovitch et al. A variable light domain fluorogen activating protein homodimerizes to activate dimethylindole red
Taussig et al. Development of proteome‐wide binding reagents for research and diagnostics
Krohl et al. A suspension cell‐based interaction platform for interrogation of membrane proteins
Stains et al. A general approach for receptor and antibody-targeted detection of native proteins utilizing split-luciferase reassembly